|
HER2-targeted therapy Clinical Trials
2 actively recruiting trials across 2 locations
Pipeline
Phase 3: 1
Top Sponsors
- SWOG Cancer Research Network1
- Memorial Sloan Kettering Cancer Center1
Indications
- Breast Cancer2
- Cancer2
- Metastatic HER2-Positive Breast Carcinoma1
- Oligometastatic Breast Carcinoma1
- Anatomic Stage IV Breast Cancer AJCC v81
Jonesboro, Arkansas1 trial
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Phase 3
Basking Ridge, New Jersey1 trial
A Study of Skipping Radiation Therapy in People With Breast Cancer
Memorial Sloan Kettering at Basking Ridge (All protocol activities)
N/A
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.